Identification of a novel GSK3β inhibitor involved in abrogating KRas dependent pancreatic tumors in Wnt/beta-catenin and NF-kB dependent manner.
Ayaz MO, Bhat AQ, Akhter Z, Badsera N, Hossain MM, Showket F, Parveen S, Dar MS, Tiwari H, Kumari N, Bhardwaj M, Hussain R, Sharma A, Kumar M, Singh U, Nargorta A, Kshatri AS, Nandi U, Monga SP, Ramajayan P, Singh PP, Dar MJ.
Ayaz MO, et al. Among authors: sharma a.
Life Sci. 2024 Jun 12:122840. doi: 10.1016/j.lfs.2024.122840. Online ahead of print.
Life Sci. 2024.
PMID: 38876185